Baidu
map

LANCET INFECT DIS:在美国阿肯色州一个高接种率的马绍尔群岛的流行性腮腺炎的爆发报告

2019-02-02 MedSci MedSci原创

在2000年至15年期间,美国阿肯色州小石城的阿肯色州卫生部每年调查1到6例流行性腮腺炎。从2016年8月5日至2017年8月5日,该部门收到超过4000例疑似流行性腮腺炎病例的报告,这是在过去30年中美国第二大疫情爆发。 <span style="font-family:宋体;mso-ascii-font-family:Calibri; mso-ascii-theme-font:mino

2000年至15年期间,美国阿肯色州小石城的阿肯色州卫生部每年调查16例流行性腮腺炎。从201685日至201785日,该部门收到超过4000例疑似流行性腮腺炎病例的报告,这是在过去30年中美国第二大疫情爆发。

阿肯色州卫生部通过调查所有报告的腮腺炎病例,以确定暴露,旅行和疫苗接种史并确定密切接触者。如果患者经实验室确认有腮腺炎病毒,或者他们有临床症状以及阳性血清学检测或已确认病例有已知流行病学联系,则将病例分类为已确诊。

研究发现,爆发期间发现2954例与暴发有关的流行性腮腺炎:1665例(56%)经实验室确认,1676例(57%)为5-17儿童1692例(57%)为马绍尔人。在1676名学龄儿童中,1536名(92%)曾接受至少两剂含有腮腺炎病毒的疫苗。虽然报告了19例睾丸炎,但未发现严重的并发症。在Marshallese个体中观察到异常,例如复发性腮腺炎和长期病毒脱落。病毒样品的特征为基因型G.

研究表明,这次大规模疫情主要影响到一个家庭拥挤密集的边缘化社区,这突显了对协调,跨学科和非传统的疫情反应的需求。这次疫情引发了关于腮腺炎疫苗有效性和潜在的免疫力下降的问题。

原始出处:                                            

Virgie S Fields, MS, Mumps in a highly vaccinated Marshallese community in Arkansas, USA: an outbreak report.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2078657, encodeId=273f20e8657f3, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sun Nov 17 15:14:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927320, encodeId=3099192e32057, content=<a href='/topic/show?id=b95b653e389' target=_blank style='color:#2F92EE;'>#流行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65373, encryptionId=b95b653e389, topicName=流行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Tue Jan 07 14:14:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737271, encodeId=b8a31e3727100, content=<a href='/topic/show?id=f5c38541851' target=_blank style='color:#2F92EE;'>#腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85418, encryptionId=f5c38541851, topicName=腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe34270299, createdName=12498561m43(暂无昵称), createdTime=Fri Feb 22 18:14:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1829945, encodeId=63c0182994545, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Sep 10 14:14:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967650, encodeId=87ef196e65046, content=<a href='/topic/show?id=102e6538037' target=_blank style='color:#2F92EE;'>#流行性腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65380, encryptionId=102e6538037, topicName=流行性腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Sep 10 03:14:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012939, encodeId=5ba820129393a, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jul 18 02:14:00 CST 2019, time=2019-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361512, encodeId=585313615125b, content=<a href='/topic/show?id=41828541441' target=_blank style='color:#2F92EE;'>#腮腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85414, encryptionId=41828541441, topicName=腮腺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Mon Feb 04 06:14:00 CST 2019, time=2019-02-04, status=1, ipAttribution=)]
    2019-11-17 gous
  2. [GetPortalCommentsPageByObjectIdResponse(id=2078657, encodeId=273f20e8657f3, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sun Nov 17 15:14:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927320, encodeId=3099192e32057, content=<a href='/topic/show?id=b95b653e389' target=_blank style='color:#2F92EE;'>#流行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65373, encryptionId=b95b653e389, topicName=流行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Tue Jan 07 14:14:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737271, encodeId=b8a31e3727100, content=<a href='/topic/show?id=f5c38541851' target=_blank style='color:#2F92EE;'>#腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85418, encryptionId=f5c38541851, topicName=腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe34270299, createdName=12498561m43(暂无昵称), createdTime=Fri Feb 22 18:14:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1829945, encodeId=63c0182994545, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Sep 10 14:14:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967650, encodeId=87ef196e65046, content=<a href='/topic/show?id=102e6538037' target=_blank style='color:#2F92EE;'>#流行性腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65380, encryptionId=102e6538037, topicName=流行性腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Sep 10 03:14:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012939, encodeId=5ba820129393a, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jul 18 02:14:00 CST 2019, time=2019-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361512, encodeId=585313615125b, content=<a href='/topic/show?id=41828541441' target=_blank style='color:#2F92EE;'>#腮腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85414, encryptionId=41828541441, topicName=腮腺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Mon Feb 04 06:14:00 CST 2019, time=2019-02-04, status=1, ipAttribution=)]
    2020-01-07 tulenzi
  3. [GetPortalCommentsPageByObjectIdResponse(id=2078657, encodeId=273f20e8657f3, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sun Nov 17 15:14:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927320, encodeId=3099192e32057, content=<a href='/topic/show?id=b95b653e389' target=_blank style='color:#2F92EE;'>#流行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65373, encryptionId=b95b653e389, topicName=流行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Tue Jan 07 14:14:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737271, encodeId=b8a31e3727100, content=<a href='/topic/show?id=f5c38541851' target=_blank style='color:#2F92EE;'>#腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85418, encryptionId=f5c38541851, topicName=腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe34270299, createdName=12498561m43(暂无昵称), createdTime=Fri Feb 22 18:14:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1829945, encodeId=63c0182994545, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Sep 10 14:14:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967650, encodeId=87ef196e65046, content=<a href='/topic/show?id=102e6538037' target=_blank style='color:#2F92EE;'>#流行性腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65380, encryptionId=102e6538037, topicName=流行性腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Sep 10 03:14:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012939, encodeId=5ba820129393a, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jul 18 02:14:00 CST 2019, time=2019-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361512, encodeId=585313615125b, content=<a href='/topic/show?id=41828541441' target=_blank style='color:#2F92EE;'>#腮腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85414, encryptionId=41828541441, topicName=腮腺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Mon Feb 04 06:14:00 CST 2019, time=2019-02-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2078657, encodeId=273f20e8657f3, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sun Nov 17 15:14:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927320, encodeId=3099192e32057, content=<a href='/topic/show?id=b95b653e389' target=_blank style='color:#2F92EE;'>#流行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65373, encryptionId=b95b653e389, topicName=流行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Tue Jan 07 14:14:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737271, encodeId=b8a31e3727100, content=<a href='/topic/show?id=f5c38541851' target=_blank style='color:#2F92EE;'>#腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85418, encryptionId=f5c38541851, topicName=腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe34270299, createdName=12498561m43(暂无昵称), createdTime=Fri Feb 22 18:14:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1829945, encodeId=63c0182994545, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Sep 10 14:14:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967650, encodeId=87ef196e65046, content=<a href='/topic/show?id=102e6538037' target=_blank style='color:#2F92EE;'>#流行性腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65380, encryptionId=102e6538037, topicName=流行性腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Sep 10 03:14:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012939, encodeId=5ba820129393a, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jul 18 02:14:00 CST 2019, time=2019-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361512, encodeId=585313615125b, content=<a href='/topic/show?id=41828541441' target=_blank style='color:#2F92EE;'>#腮腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85414, encryptionId=41828541441, topicName=腮腺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Mon Feb 04 06:14:00 CST 2019, time=2019-02-04, status=1, ipAttribution=)]
    2019-09-10 howi
  5. [GetPortalCommentsPageByObjectIdResponse(id=2078657, encodeId=273f20e8657f3, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sun Nov 17 15:14:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927320, encodeId=3099192e32057, content=<a href='/topic/show?id=b95b653e389' target=_blank style='color:#2F92EE;'>#流行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65373, encryptionId=b95b653e389, topicName=流行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Tue Jan 07 14:14:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737271, encodeId=b8a31e3727100, content=<a href='/topic/show?id=f5c38541851' target=_blank style='color:#2F92EE;'>#腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85418, encryptionId=f5c38541851, topicName=腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe34270299, createdName=12498561m43(暂无昵称), createdTime=Fri Feb 22 18:14:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1829945, encodeId=63c0182994545, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Sep 10 14:14:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967650, encodeId=87ef196e65046, content=<a href='/topic/show?id=102e6538037' target=_blank style='color:#2F92EE;'>#流行性腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65380, encryptionId=102e6538037, topicName=流行性腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Sep 10 03:14:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012939, encodeId=5ba820129393a, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jul 18 02:14:00 CST 2019, time=2019-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361512, encodeId=585313615125b, content=<a href='/topic/show?id=41828541441' target=_blank style='color:#2F92EE;'>#腮腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85414, encryptionId=41828541441, topicName=腮腺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Mon Feb 04 06:14:00 CST 2019, time=2019-02-04, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2078657, encodeId=273f20e8657f3, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sun Nov 17 15:14:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927320, encodeId=3099192e32057, content=<a href='/topic/show?id=b95b653e389' target=_blank style='color:#2F92EE;'>#流行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65373, encryptionId=b95b653e389, topicName=流行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Tue Jan 07 14:14:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737271, encodeId=b8a31e3727100, content=<a href='/topic/show?id=f5c38541851' target=_blank style='color:#2F92EE;'>#腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85418, encryptionId=f5c38541851, topicName=腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe34270299, createdName=12498561m43(暂无昵称), createdTime=Fri Feb 22 18:14:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1829945, encodeId=63c0182994545, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Sep 10 14:14:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967650, encodeId=87ef196e65046, content=<a href='/topic/show?id=102e6538037' target=_blank style='color:#2F92EE;'>#流行性腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65380, encryptionId=102e6538037, topicName=流行性腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Sep 10 03:14:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012939, encodeId=5ba820129393a, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jul 18 02:14:00 CST 2019, time=2019-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361512, encodeId=585313615125b, content=<a href='/topic/show?id=41828541441' target=_blank style='color:#2F92EE;'>#腮腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85414, encryptionId=41828541441, topicName=腮腺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Mon Feb 04 06:14:00 CST 2019, time=2019-02-04, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=2078657, encodeId=273f20e8657f3, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sun Nov 17 15:14:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927320, encodeId=3099192e32057, content=<a href='/topic/show?id=b95b653e389' target=_blank style='color:#2F92EE;'>#流行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65373, encryptionId=b95b653e389, topicName=流行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Tue Jan 07 14:14:00 CST 2020, time=2020-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737271, encodeId=b8a31e3727100, content=<a href='/topic/show?id=f5c38541851' target=_blank style='color:#2F92EE;'>#腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85418, encryptionId=f5c38541851, topicName=腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe34270299, createdName=12498561m43(暂无昵称), createdTime=Fri Feb 22 18:14:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1829945, encodeId=63c0182994545, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Sep 10 14:14:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967650, encodeId=87ef196e65046, content=<a href='/topic/show?id=102e6538037' target=_blank style='color:#2F92EE;'>#流行性腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65380, encryptionId=102e6538037, topicName=流行性腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Sep 10 03:14:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2012939, encodeId=5ba820129393a, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jul 18 02:14:00 CST 2019, time=2019-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361512, encodeId=585313615125b, content=<a href='/topic/show?id=41828541441' target=_blank style='color:#2F92EE;'>#腮腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85414, encryptionId=41828541441, topicName=腮腺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Mon Feb 04 06:14:00 CST 2019, time=2019-02-04, status=1, ipAttribution=)]
    2019-02-04 mfx799

相关资讯

LANCET INFECT DIS:尽管疫苗覆盖率很高,但在西澳大利亚州发生了长期流行性腮腺炎疫情?

在2007 - 08年,尽管疫苗覆盖率很高,但在西澳大利亚州北部的土着居民中仍然暴发了基因型J腮腺炎。2015年3月,西澳大利亚州北部暴发了第二次长期流行性腮腺炎,并在该州农村地区广泛传播。这次爆发是由基因型G病毒引起的,并且再次主要影响原住民。本研究的目的是描述这次疫情的流行病学。 · 2019-02-02

-->

流行性腮腺炎来了!如何预防?

在前不久国家卫健委发布的《2018年8月全国法定传染病疫情概况》中,流行性腮腺炎的发病数高达16801例,排在丙类传染病发病数第二位,仅次于手足口病。

Baidu
map
Baidu
map
Baidu
map